Astria Therapeutics (ATXS) Q4 2023 Earnings

4MarConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-0.86
-0.71
-0.55
-0.4

Details

Expected EPS
-0.78
Actual EPS
-0.86
Surprise EPS
-0.08
Surprise Percent
+10.26%

Description

Astria Therapeutics (ATXS) has reported earnings of -0.86 per share for Q4 2023.

0 Comments

Share your thoughts